Literature DB >> 25126379

Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Fei Li1, Shao-Zhen Zhao1.   

Abstract

Corneal diseases are a major cause of blindness in the world. Although great progress has been achieved in the treatment of corneal diseases, wound healing after severe corneal damage and immunosuppressive therapy after corneal transplantation remain problematic. Mesenchymal stem cells (MSCs) derived from bone marrow or other adult tissues can differentiate into various types of mesenchymal lineages, such as osteocytes, adipocytes, and chondrocytes, both in vivo and in vitro. These cells can further differentiate into specific cell types under specific conditions. MSCs migrate to injury sites and promote wound healing by secreting anti-inflammatory and growth factors. In addition, MSCs interact with innate and acquired immune cells and modulate the immune response through their powerful paracrine function. Over the last decade, MSCs have drawn considerable attention because of their beneficial properties and promising therapeutic prospective. Furthermore, MSCs have been applied to various studies related to wound healing, autoimmune diseases, and organ transplantation. This review discusses the potential functions of MSCs in protecting corneal tissue and their possible mechanisms in corneal wound healing and corneal transplantation.

Entities:  

Keywords:  Corneal injury; Immune modulation; Mesenchymal stem cells; Transplantation; Wound repair

Year:  2014        PMID: 25126379      PMCID: PMC4131271          DOI: 10.4252/wjsc.v6.i3.296

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  92 in total

1.  Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells.

Authors:  F R Li; X G Wang; C Y Deng; H Qi; L L Ren; H X Zhou
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6.

Authors:  Gavin W Roddy; Joo Youn Oh; Ryang Hwa Lee; Thomas J Bartosh; Joni Ylostalo; Katie Coble; Robert H Rosa; Darwin J Prockop
Journal:  Stem Cells       Date:  2011-10       Impact factor: 6.277

Review 3.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

4.  Perivascular multipotent progenitor cells in human organs.

Authors:  Mihaela Crisan; Chien-Wen Chen; Mirko Corselli; Gabriella Andriolo; Lorenza Lazzari; Bruno Péault
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

5.  Effects of bone marrow mesenchymal stem cells on cell proliferation and growth factor expression of limbal epithelial cells in vitro.

Authors:  Nan Hu; Yuan-Yuan Zhang; Hong-Wei Gu; Huai-Jin Guan
Journal:  Ophthalmic Res       Date:  2012       Impact factor: 2.892

6.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

7.  Altered KSPG expression by keratocytes following corneal injury.

Authors:  Eric C Carlson; I-Jong Wang; Chia-Yang Liu; Paul Brannan; Candace W C Kao; Winston W Y Kao
Journal:  Mol Vis       Date:  2003-11-21       Impact factor: 2.367

8.  Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency.

Authors:  Thomas Reinhard; Helga Spelsberg; Lotte Henke; Theodoros Kontopoulos; Jürgen Enczmann; Peter Wernet; Peter Berschick; Rainer Sundmacher; Daniel Böhringer
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

Review 9.  Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms.

Authors:  Timothy J Cashman; Valerie Gouon-Evans; Kevin D Costa
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 10.  Mesenchymal stem cells: angels or demons?

Authors:  Rebecca S Y Wong
Journal:  J Biomed Biotechnol       Date:  2011-07-24
View more
  18 in total

1.  Peripheral Blood As a Source of Stem Cells for Regenerative Medicine: Emphasis Towards Corneal Epithelial Reconstruction-An In Vitro Study.

Authors:  Balu Venugopal; Sumitha Mohan; T V Kumary; P R Anil Kumar
Journal:  Tissue Eng Regen Med       Date:  2020-06-22       Impact factor: 4.169

Review 2.  Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.

Authors:  Mohaddeseh Rahbaran; Angelina Olegovna Zekiy; Mahta Bahramali; Mohammadsaleh Jahangir; Mahsa Mardasi; Delaram Sakhaei; Lakshmi Thangavelu; Navid Shomali; Majid Zamani; Ali Mohammadi; Negin Rahnama
Journal:  Cell Mol Biol Lett       Date:  2022-07-16       Impact factor: 8.702

Review 3.  The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas.

Authors:  Fu-Shin X Yu; Patrick S Y Lee; Lingling Yang; Nan Gao; Yangyang Zhang; Alexander V Ljubimov; Ellen Yang; Qingjun Zhou; Lixin Xie
Journal:  Prog Retin Eye Res       Date:  2022-01-04       Impact factor: 19.704

4.  Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation.

Authors:  Celine J Rocca; Alexander Kreymerman; Sarah N Ur; Katie E Frizzi; Swati Naphade; Athena Lau; Tammy Tran; Nigel A Calcutt; Jeffrey L Goldberg; Stephanie Cherqui
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

Review 5.  Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases.

Authors:  Bo Yu; Xiao-Rong Li; Xiao-Min Zhang
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

6.  Corneal Repair with Adhesive Cell Sheets of Fetal Cartilage-Derived Stem Cells.

Authors:  Byeong Kook Kim; In-Su Park; Minh-Dung Truong; Hong Seok Yang; Sang-Hyug Park; Hyo Soon Park; Byung Hyune Choi; Bae Hie Won; Byoung-Hyun Min
Journal:  Tissue Eng Regen Med       Date:  2021-01-07       Impact factor: 4.169

7.  Salidroside-pretreated mesenchymal stem cells contribute to neuroprotection in cerebral ischemic injury in vitro and in vivo.

Authors:  Liping Zhou; Panpan Yao; Lixia Jiang; Zhaoyun Wang; Xiaohe Ma; Guangxin Wen; Jintao Yang; Binjie Zhou; Qin Yu
Journal:  J Mol Histol       Date:  2021-09-27       Impact factor: 2.611

8.  Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.

Authors:  Christophe Roubeix; David Godefroy; Céline Mias; Anaïs Sapienza; Luisa Riancho; Julie Degardin; Valérie Fradot; Ivana Ivkovic; Serge Picaud; Florian Sennlaub; Alexandre Denoyer; William Rostene; José Alain Sahel; Stéphane Melik Parsadaniantz; Françoise Brignole-Baudouin; Christophe Baudouin
Journal:  Stem Cell Res Ther       Date:  2015-09-16       Impact factor: 6.832

9.  The Comparison of Adipose Stem Cell and Placental Stem Cell in Secretion Characteristics and in Facial Antiaging.

Authors:  Yan Xu; Shilei Guo; Cui Wei; Honglan Li; Lei Chen; Chang Yin; Chuansen Zhang
Journal:  Stem Cells Int       Date:  2016-02-08       Impact factor: 5.443

Review 10.  Mesenchymal stem cells for treating ocular surface diseases.

Authors:  Liyun Zhang; Vivien Jane Coulson-Thomas; Tarsis Gesteira Ferreira; Winston W Y Kao
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.